Merit Medical Systems, Inc. $MMSI Shares Acquired by Peak Retirement Planning Inc.

Peak Retirement Planning Inc. lifted its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 35.4% during the 4th quarter, HoldingsChannel.com reports. The fund owned 32,472 shares of the medical instruments supplier’s stock after buying an additional 8,494 shares during the period. Merit Medical Systems makes up about 0.7% of Peak Retirement Planning Inc.’s portfolio, making the stock its 28th biggest holding. Peak Retirement Planning Inc.’s holdings in Merit Medical Systems were worth $2,862,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Maseco LLP acquired a new position in shares of Merit Medical Systems during the 4th quarter valued at $26,000. Torren Management LLC acquired a new position in shares of Merit Medical Systems during the 4th quarter valued at $38,000. Covestor Ltd lifted its holdings in shares of Merit Medical Systems by 252.6% during the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after acquiring an additional 336 shares in the last quarter. Danske Bank A S acquired a new position in shares of Merit Medical Systems during the 3rd quarter valued at $42,000. Finally, Quarry LP lifted its holdings in shares of Merit Medical Systems by 185.9% during the 3rd quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock valued at $44,000 after acquiring an additional 342 shares in the last quarter. Institutional investors and hedge funds own 99.66% of the company’s stock.

Analyst Upgrades and Downgrades

MMSI has been the topic of several recent research reports. Robert W. Baird set a $83.00 target price on shares of Merit Medical Systems in a report on Friday, May 1st. Wells Fargo & Company reduced their target price on shares of Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Citigroup restated an “outperform” rating on shares of Merit Medical Systems in a report on Monday, April 20th. BTIG Research started coverage on shares of Merit Medical Systems in a report on Friday, February 6th. They issued a “buy” rating and a $107.00 price objective on the stock. Finally, Canaccord Genuity Group cut their price objective on shares of Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Eight analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Merit Medical Systems presently has an average rating of “Moderate Buy” and a consensus target price of $92.80.

Merit Medical Systems Stock Performance

Shares of MMSI stock opened at $60.89 on Wednesday. Merit Medical Systems, Inc. has a 12 month low of $59.74 and a 12 month high of $96.74. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.08 and a quick ratio of 3.46. The firm has a market capitalization of $3.63 billion, a P/E ratio of 26.36, a P/E/G ratio of 1.93 and a beta of 0.54. The company’s fifty day moving average price is $66.18 and its two-hundred day moving average price is $76.68.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The firm had revenue of $381.88 million for the quarter, compared to analyst estimates of $377.59 million. During the same quarter in the previous year, the business posted $0.86 EPS. The firm’s revenue was up 7.4% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, research analysts anticipate that Merit Medical Systems, Inc. will post 3.62 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Lynne N. Ward sold 5,000 shares of the company’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $62.61, for a total value of $313,050.00. Following the sale, the director owned 7,809 shares in the company, valued at approximately $488,921.49. This represents a 39.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Brian G. Lloyd bought 2,000 shares of the business’s stock in a transaction dated Thursday, May 7th. The stock was bought at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the purchase, the insider owned 2,000 shares in the company, valued at approximately $125,240. This represents a ? increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.